925P Analytical performance of a next-generation sequencing (NGS) assay kit for assessing homologous recombination deficiency (HRD) from solid tumor samples
L. Liu(Illumina (United States)), J. Day(Illumina (United States)), B. Hariharan(Illumina (United States)), F. Song(Illumina (United States)), Y. Ding(Illumina (United States)), Raakhee Vijayaraghavan(Illumina (United States)), Janel Dockter(Illumina (United States)), Sven Bilke(Illumina (United States)), Traci Pawlowski(Illumina (United States)), Paul Wenz(Illumina (United States)), Yao Fu(Illumina (United States)), Samuel G. Katz(Yale University), J. Lee(Illumina (United States)), Yunjiao Zhu(Illumina (United States)), H. Yan(Illumina (United States)), C. Schulman(Illumina (United States)), D. Erlandson(Illumina (United States)), E. Xia(Illumina (United States)), Chen Zhao(Illumina (United States)), Kyria Roessler(Illumina (United States))
Cited by 3
Related Papers
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530